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To enable the development of a tandem mass spectrometry (MS/MS) based methodology for
selective protein identification and differential quantitative analysis, a novel derivatization
strategy is proposed, based on the formation of a “fixed-charge” sulfonium ion on the
side-chain of a methionine amino acid residue contained within a protein or peptide of
interest. The gas-phase fragmentation behavior of these side chain fixed charge sulfonium ion
containing peptides is observed to result in exclusive loss of the derivatized side chain and the
formation of a single characteristic product ion, independently of charge state or amino acid
composition. Thus, fixed charge containing peptide ions may be selectively identified from
complex mixtures, for example, by selective neutral loss scan mode MS/MS methods. Further
structural interrogation of identified peptide ions may be achieved by subjecting the charac-
teristic MS/MS product ion to multistage MS/MS (MS3) in a quadrupole ion trap mass
spectrometer, or by energy resolved “pseudo” MS3 in a triple quadrupole mass spectrometer.
The general principles underlying this fixed charge derivatization approach are demonstrated
here by MS/MS, MS3 and “pseudo” MS3 analysis of side chain fixed-charge sulfonium ion
derivatives of peptides containing methionine formed by reaction with phenacylbromide.
Incorporation of “light” and “heavy” isotopically encoded labels into the fixed-charge
derivatives facilitates the application of this method to the quantitative analysis of differential
protein expression, via measurement of the relative abundances of the neutral loss product
ions generated by dissociation of the light and heavy labeled peptide ions. This approach,
termed “selective extraction of labeled entities by charge derivatization and tandem mass
spectrometry” (SELECT), thereby offers the potential for significantly improved sensitivity
and selectivity for the identification and quantitative analysis of peptides or proteins
containing selected structural features, without requirement for extensive fractionation or
otherwise enrichment from a complex mixture prior to analysis. (J Am Soc Mass Spectrom
2005, 16, 1131–1150) © 2005 American Society for Mass SpectrometryProteomic studies involving the comprehensiveidentification, characterization, and quantitativeanalysis of all the gene products, i.e., proteins
expressed by a particular cell or tissue type at a given
time, together with the systematic characterization of
their specific functional interactions, have recently
emerged as a means to determine the hitherto unknown
functional role of the thousands of genes identified
from recent genome sequencing initiatives [1, 2]. It is
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doi:10.1016/j.jasms.2005.03.015widely anticipated that one of the major outcomes of
these studies will be a more complete understanding of
the processes that control cellular biochemistry, as well
as allowing the development of novel therapeutic
agents targeted toward specific biomarkers of disease.
Substantial progress in the field has been achieved in
recent years, primarily via the application of mass
spectrometry (MS) instrumentation and associated sam-
ple handling methodologies, together with the develop-
ment of sophisticated bioinformatic tools, for rapid
protein identification and characterization [3]. How-
ever, there are a number of issues that currently limit
the ability of these mass spectrometry based approaches
to translate the “promise” of proteomics into “practice”.
Foremost among these is the significant analytical chal-
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range and diversity of transcriptional, translation, and
post translational modifications associated with the
proteome, which is in a constant state of spatial and
temporal flux throughout the cell cycle.
Mass Spectrometry (MS) Methods for Selective
Protein Identification and Quantitative Analysis
In a typical approach to protein identification and
characterization, complex protein mixtures or individ-
ual proteins resolved by electrophoretic or chromato-
graphic methods are subjected to proteolysis, and the
resultant peptide mixtures then introduced to the mass
spectrometer by on-line chromatography. Following
determination of their masses, individual peptide ions
are then selected for sequence analysis by tandem mass
spectrometry (MS/MS) [4]. Subsequently, protein iden-
tification may be achieved by database analysis of the
uninterrupted product ion spectrum [5], by database
searching of a partially derived amino acid “sequence
tag” [6], or by “de-novo” sequence analysis [4]. A major
limitation of this analysis strategy however, is that
proteolytic digestion increases the complexity of the
component mixture by up to several orders of magni-
tude, thereby placing significant demands on the per-
formance of the analytical methodologies employed for
peptide separation and analysis. Furthermore, although
affinity purification [7] and off- and on-line multidi-
mensional chromatographic [8] approaches have been
developed for simplification of these complex peptide
mixtures prior to MS, and dynamic exclusion methods
[9, 10] have been developed to allow greater numbers of
distinct peptide ions to be selected for MS/MS analysis,
information regarding the identity of proteins repre-
sented as low abundance peptides is commonly not
obtained, thereby limiting the dynamic range [11].
Issues associated with mixture complexity and dy-
namic range also present a challenge to the application
of mass spectrometry to the quantitative analysis of
protein abundances observed between two different
states of a biological system, such as that encountered
between normal versus diseased cells. To date, the
majority of these methods have employed either in vivo
metabolic labeling [12–14] or in vitro chemical deriva-
tization [15–34] to introduce a characteristic differential
isotopic mass “tag” between two different samples of
interest. The samples are then combined and the pro-
teins subjected to proteolysis (this order may be re-
versed if differential labeling occurs during or follow-
ing the proteolytic digestion step), and the masses of the
resultant peptides determined by MS. By comparing the
relative abundances of peptide ions originating from an
isotopically enriched sample with those originating
from a sample prepared using naturally abundant iso-
topes, quantitation of differences in protein abundance
between the two samples may be obtained. All these
methods for quantitation, however, have been based ona common approach for identification of the differential
mass “signature” between the two samples, i.e., by
mass analysis of their intact peptide precursor ions.
Limitations to this general analysis strategy may be
encountered, therefore, when (1) separation of the dif-
ferentially labeled “light” and “heavy” peptides occurs
during chromatographic fractionation of the peptide
mixture [35, 36], (2) the m/z values of differentially
labeled peptide ions overlap with nonlabeled peptide
components present in the mixture, or (3) one or both of
the differentially labeled peptide ions of interest are
present at, or below, the limit of detection of the mass
spectrometer [37]. The use of 13C instead of 2H labeling
has been employed to eliminate the deuterium isotope
effect responsible for the first of these limitations [33].
The second limitation has been at least partially ad-
dressed by the application of strategies for selective
enrichment of labeled peptides prior to MS analysis, via
affinity purification [15] or solid phase capture [34], or
by methods for extensive multidimensional chromato-
graphic fractionation of peptide mixtures prior to anal-
ysis [38, 39]. To date, however, limitations associated
with the detection of low abundance differentially la-
beled peptide ions via conventional MS based methods
have proven difficult to address.
Tandem Mass Spectrometry (MS/MS) Methods
for Selective Protein Identification
and Quantitative Analysis
Recently, an MS/MS based “tandem mass tag” ap-
proach for differential quantitative protein analysis has
been described that holds promise in addressing this
problem [40]. This method is based on measurement of
the relative abundances of characteristic isotopically
encoded low mass product ions formed by MS/MS
from N-terminally derivatized peptides. Similar ap-
proaches, employing precursor ion or neutral loss
MS/MS scan modes [41], whereby the mass spectrom-
eter is set to detect a characteristic low mass product
ion, or a characteristic product ion offset by a given
mass from the selected precursor, respectively, have
been extensively employed in the past for the selective
identification of peptide ions containing certain struc-
tural features (e.g., particular amino acid residues [42],
post-translational modifications [43– 49], or chemical
cross linking agents [50]). Because of the reduction in
chemical noise associated with the MS/MS experiment,
these methods have been demonstrated to yield greater
specificity and increase sensitivity by 1 to 2 orders of
magnitude over conventional MS based detection meth-
ods, and to enable the detection of low abundance
precursor ions that may not otherwise be apparent in
the MS experiment, i.e., below the level of chemical
noise [37]. One of the major limitations of all these
methods, however, is that the desired fragmentation
pathway giving rise to the product ion of interest is
typically only one of many dissociation channels,
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namic range.
The reason for a desired fragmentation pathway
often not yielding a dominant product ion may be
rationalized by taking into consideration the generally
accepted mechanisms and other factors (such as peptide
ion charge state and amino acid composition) known to
be responsible for the gas-phase dissociation reactions
of protonated peptide ions. Under low-energy colli-
sional activation conditions, the cleavage of most bonds
within a protonated peptide ion is thought to require
localization of an ionizing proton at the cleavage site.
Fragmentation then proceeds via “charge-directed”
neighboring group participation mechanisms involving
nucleophilic attack from an adjacent functional group
[51–54]. The formation of product ions resulting from
“enhanced” cleavage at the N-terminal side of proline
residues has been consistently noted in the literature,
presumably because of the higher local proton affinity
of the proline imide bond compared with a conven-
tional amide bond. However, consistent with the idea
that the strongly basic guanidino side chain of arginine
residues may act to strongly “sequester” ionizing pro-
tons, thereby limiting their ability to be transferred
along the peptide backbone to initiate cleavage by
charge-directed pathways, a recent report has demon-
strated that enhanced proline cleavage is only observed
as a dominant process under conditions where the
number of ionizing protons is greater than the number
of arginine residues contained within the peptide ion
[55]. Indeed, under conditions where the number of
ionizing protons is less than or equal to the number of
arginine residues within the peptide ion, enhanced
cleavages at other sites along the peptide backbone via
“charge-remote” mechanisms, for example at the C-
terminal side of aspartic acid residues or at the side
chains of methionine sulfoxide residues, are commonly
observed [55, 56].
The derivatization reagent employed in the “tandem
mass tag” strategy described above contains a fragmen-
tation “enhancement” group consisting of a proline
residue to promote cleavage within the label during
MS/MS, as well as a “sensitization” group containing a
guanidino group to promote formation of a character-
istic protonated low mass product ion following the
fragmentation reaction [40]. However, the presence of
the guanidino “sensitization” group may actually act to
limit proton mobility, and thereby hinder the desired
fragmentation pathway from proceeding. Therefore, the
formation of abundant low mass product ions charac-
teristic of “tandem mass tag” derivatized peptides are
only expected for a sub-set of the total peptide ions
presented to the mass spectrometer for dissociation.
Here, to address this problem and to facilitate the
development of a general MS/MS based approach for
selective protein identification and differential quanti-
tative analysis, we propose a novel derivatization strat-
egy, termed selective extraction of labeled entities by
charge derivatization and tandem mass spectrometry(SELECT), that is based on the formation of a “fixed-
charge” on the side-chain of a selected amino acid
residue contained within a protein or peptide of inter-
est. Although fixed charge derivatization strategies for
peptides have been used previously in conjunction with
MS/MS for sequencing applications, most prior work
has been limited to derivatization of the N- and C-
termini, as well as lysine and arginine side chains, and
has been focused on directing fragmentation toward the
formation of a particular series of backbone cleavage
derived sequence ions (i.e., maximizing sequence cov-
erage) [57– 62]. In contrast, the MS/MS dissociation of
peptide ions containing the fixed charge derivatives
described here are directed toward the exclusive forma-
tion of a single characteristic side chain product ion,
independently of the amino acid composition, proton
mobility, or precursor ion charge state. These fixed
charge containing peptide ions may therefore be readily
identified from complex mixtures, for example, by
selective neutral loss scan mode MS/MS methods.
Further structural interrogation of peptide ions identi-
fied by the fixed charge derivatization approach may be
achieved by subjecting the characteristic MS/MS prod-
uct ion to multistage MS/MS (MS3) in a quadrupole ion
trap mass spectrometer, or by energy resolved
“pseudo” MS3 in a triple quadrupole mass spectrome-
ter. Incorporation of “light” and “heavy” isotopically
encoded labels into the fixed-charge derivatives also
facilitates the application of this MS/MS method to the
quantitative analysis of differential protein expression.
The SELECT fixed-charge derivatization approach
thereby offers the potential for significantly improved
sensitivity and selectivity for the identification and
quantitative analysis of peptides or proteins containing
certain structural features, without the requirement for
extensive fractionation or otherwise enrichment from a
complex mixture prior to analysis.
Materials and Methods
Materials
The synthetic peptides GAILMGAILA, GAILMGAILK,
GAILMGAILR, VTMGHFCNFGK, and VTMGHFDN-
FGR were purchased from Auspep (Melbourne, Austra-
lia). Iodomethane, iodoethane, iodobenzene, iodomethyl-
benzene, d5-acetophenone, and poly(4-vinylpyridinium
tribromide) were obtained from Aldrich (Castle Hill, Aus-
tralia). Phenacylbromide was purchased from Fluka (Cas-
tle Hill, Australia). Iodoacetic acid and iodoacetamide
were from Sigma (St. Louis, MI). Methanol, and acetoni-
trile (Chromar grade) were purchased from Mallinkrodt
(Paris, KY). Acetic acid was obtained from BDH Labora-
tories (Poole, United Kingdom). All solutions were pre-
pared using deionizedwater purified by a tandemMilli-Q
and Milli-RO system (Millipore, Bedford, MA). Unless
stated otherwise, all reagents were AR grade and used as
supplied without further purification.
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2=,3=,4=,5=,6=-2H5-phenacylbromide was synthesized ac-
cording to the method of Frechet et al. [63] Briefly,
2=,3=,4=,5=,6=-2H5-acetophenone (1 mmol, 1.25 mL) was
added to poly(4-vinylpyridinium tribromide) (4.8 g ,3
meq Br3
/g resin) in 30 mL methanol, then allowed to
react with stirring at room temperature for 4 h. The
resultant -bromo ketone was obtained in pure form by
filtration of the reaction mixture, followed by evapora-
tion of the solvent and recrystallization prior to use.
Side Chain Fixed-Charge Derivatization
of Methionine-Containing Peptides
Side chain fixed-charge sulfonium ion derivatives of
synthetic methionine-containing model “tryptic” pep-
tides were produced by the addition of 10 L of a 1M
solution of alkylating reagent to 100 g of peptide
dissolved in 100 L of aqueous 20% HOAc containing
30% CH3CN. The reaction was allowed to proceed for
24 h at room temperature after which the sample was
diluted then introduced to the mass spectrometer with
no further purification.
Mass Spectrometry
Mass spectrometric analysis was performed using (1)
quadrupole ion trap (Thermo-Finnigan model LCQ, San
Jose, CA), (2) quadrupole-time-of-flight (Micromass
model Q-TOF2, Manchester, UK), or (3) triple quadru-
pole (Thermo-Finnigan model TSQ, San Jose, CA) mass
spectrometers, each equipped with electrospray ioniza-
tion (ESI) interfaces.
Quadrupole Ion Trap Mass Spectrometry
Samples (10 pmol/L in 50:50:1 H2O/CH3CN/HOAc)
were introduced to the mass spectrometer by electro-
spray ionization at 2 L/min. ESI conditions were
optimized to maximize the intensity of the ion of
interest and to minimize the extent of “in-source”
fragmentation. Typical conditions were: spray voltage
5 kV, nitrogen sheath gas, 30 psi, heated capillary
temperature 150 °C. MS/MS andMS3 experiments were
performed on mass selected ions using standard isola-
tion and excitation procedures. All spectra shown were
the average of 10 scans.
Quadrupole-Time-Of-Flight Mass Spectrometry
Samples (10 pmol/L in 50:50:1 H2O/CH3CN/ HOAc)
were introduced to the mass spectrometer by electro-
spray ionization at 1 L/min. Electrospray interface
conditions were optimized to maximize the intensity of
the ion of interest. Typical conditions were: spray
voltage, 4.5 kV; nitrogen source gas, 1 psi; cone gas,
100 (arbitrary units); source temperature, 50 °C; desol-
vation temperature, 150 °C; cone voltage, 50 V (forsingly charged ions), 30 V (for doubly charged ions),
and 20 V (for triply charged ions). Energy resolved CID
MS/MS experiments were acquired using argon as the
inert collision gas at a pressure of 10 psi. The collision
energy was ramped from 4 to 58 V in 1 V increments for
singly charged ions, from 4 to 20 V in 1 V increments for
doubly charged ions, and from 20 to 46 V in 2 V
increments for triply charged ions. Spectra were ac-
quired using the V-optics mode of the time-of-flight
mass analyzer. Spectra obtained at each collision energy
value were the average of 10 scans.
Triple Quadrupole Mass Spectrometry
Samples (1 pmol/L in 50:50:1 H2O/CH3CN/ HOAc)
were introduced to the mass spectrometer by a home
built nano-electrospray ionization source at a flow rate
of 200 nL/min. The spray voltage was maintained at
1.8 kV. The heated capillary temperature was 150 °C.
The argon collision gas pressure was maintained at 1.5
mTorr. The instrument was operated under unit reso-
lution conditions. Neutral loss mode MS/MS scans
(neutral losses of 83 and 85.5 Thomson (Th) for d0- and
d5-containing doubly charged ions, and 55.3 and 57 Th
for d0- and d5-containing triply charged ions) were
performed at collision energies of 18 and 13 V, respec-
tively. Product ion CID MS/MS spectra of peptide ions
selectively identified by neutral loss scans were then
acquired at 18 and 31 V for doubly charged ions and 13
and 18 V for triply charged ions. All spectra shown
were the average of 20 scans.
On-line capillary RP-HPLC was performed using (1)
a 200 m i.d.  150 mm fused silica column, packed
with Brownlee RP-300, 7 m dimethyloctyl silica, de-
veloped at a flow rate of 3.6 L min1 using a linear 60
min gradient from 0–100% B, or (2) a 75 m i.d.  150
mm fused silica column, packed with Vydac C4, devel-
oped at a flow rate of 200 nL min1 using a linear 60
min gradient from 0–100% B. In both cases, Solvent A
was 0.1 M HOAc, and Solvent B was 0.1 M HOAc
containing 60% CH3CN.
Results and Discussion
The general principles underlying the SELECT side
chain fixed charge derivatization approach for protein
identification and differential quantitation are demon-
strated here by MS/MS and MS3 analysis of fixed-
charge sulfonium ion derivatives of peptides containing
methionine. Analysis of release 45.2 of the SWISS-PROT
database indicates that while the occurrence of methio-
nine residues in the database is only 2.37%, 96.9% of the
individual protein entries within the database contain
at least one methionine residue, thereby satisfying the
criteria that approaches for selective protein identifica-
tion and quantitative analysis should minimize the
number of peptides to be identified, while providing
comprehensive proteome coverage.Identification of methionine-containing peptides via
heme
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atives is attractive for several reasons The chemistry
and biological applications of sulfonium ions are well
documented [64 –78]. The alkylation of methionine res-
idues in proteins and peptides is specific at low pH
regardless of the alkylating reagent used, because the
rate of alkylation of the thioether sulfur atom of the
methionine side chain is virtually independent of pH
(even down to pH1) [65, 66]. In contrast, the reactivity
of all other nucleophilic functional groups (e.g., cys-
teine, lysine and histidine residues) decreases at low pH
because of the protonation. In a previous experiment
aimed at elucidating the gas-phase fragmentation reac-
tions of protonated amino acids by MS/MS, fixed-
charge side chain sulfonium ion derivatives of methio-
nine and S-methyl cysteine were observed to fragment
exclusively via neutral loss of the side chain CH3SR1,
where R1 was a substituted alkyl group [79, 80] (Scheme
1). This loss has also been observed previously for
peptides [81] and proteins [82].
Solution and Gas-Phase Requirements for Fixed-
Charge Sulfonium Ion Derivatization of
Methionine Containing Peptides
In order for the fixed charge derivatization strategy to
be successful, both the solution-phase reactivity and the
gas-phase ion chemistry of the resultant sulfonium ions
must be considered. The requirements for sulfonium
ion formation in solution include (1) that reactions
should be easy to perform using readily available
alkylating reagents, (2) that the derivatization reaction
ScSchemeshould be specific to the desired amino acid residue and
proceed to completion, and (3) that the resultant sulfo-
nium ion be chemically and thermally stable [65, 83, 84].
Many of the potentially useful reagents of interest are
commercially available. Others may be synthesized
from commercially available precursors by using sim-
ple methods described in the literature. For example,
stable isotope labeled 2=,3=,4=,5=,6=-2H5-phenacylbro-
mide may be readily prepared from 2=,3=,4=,5=,6=-2H5-
acetophenone in a one-step process as outlined in the
Materials and Methods section above.
The reactivity and stability of a range of potential
alkylating reagents for methionine side chain fixed-
charge sulfonium ion formation, including iodometh-
ane, iodoethane, iodobenzene, iodomethylbenzene, io-
doacetic acid, iodoacetamide, and phenacylbromide
have been evaluated by reaction with the model peptide
GAILMGAILK. The peptide was reacted with a 100-fold
molar excess of each alkylating reagent for 4, 8, 16, or
32 h before being analyzed by mass spectrometry to
determine the extent of reaction. After 16 h, only the
phenacyl derivative had reacted to completion [85– 87].
The ethyl derivative was found to have the least reac-
tivity and stability in solution (only 1% reaction after
16 h). All other reagents ranged in reactivity between
these two extremes. The phenacyl sulfonium ion deriv-
ative was found to be stable in solution for several
weeks without significant degradation. All the sulfo-
nium ions examined, including those with poor reactiv-
ity in solution, were found to be sufficiently stable to
allow their introduction to the mass spectrometer by
electrospray ionization.
12
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shown to effect the reversal of the alkylation of methi-
onine residues [88], and transfer of a methyl group from
a sulfonium salt to a free sulfhydryl acceptor is a well
known possible side reaction [89 –91], S-alkylation of
cysteine residues prior to methionine sulfonium ion
formation may be required. However, S-alkylation of a
cysteine residue to yield the derivative (CHCH2SR2)
[step (i) of Scheme 2] may also result in the subsequent
formation of a fixed charge sulfonium ion derivative
under identical conditions to those employed for alky-
lation of methionine, provided that the initial S-alkyl
derivative is stable to sulfonium ion formation [step (ii)
in Scheme 2]. Although differentiation between sulfo-
nium ion derivatives of methionine and stable sulfo-
nium ion derivatives of S-alkyl cysteine residues may
be readily achieved during MS/MS by using an alkyl
Scgroup R2 which is NOT a methyl group, initial cysteinealkylation conditions could also be chosen so that the
S-alkyl derivative is not stable to sulfonium ion forma-
tion, thereby allowing specific derivatization of methi-
onine containing peptides only.
A key requirement of this work is that the fixed
charge derivatives dissociate to yield a single character-
istic product ion via cleavage of the -CH2-S linkage
adjacent to the fixed charge upon MS/MS fragmenta-
tion (Scheme 1). Thus, side reactions such as charge
migration via intramolecular proton transfer, alkyl
group transfer, as well as breaking of bonds to give
stable alkyl cations or alkenes must be avoided [92–
100]. Proton transfer (Scheme 3, Pathway 1) would give
an sulfur ylide. Although the acidity of the (CH3)3S
 ion
[or the proton affinity of the conjugate base
(CH3)2S(CH2)] is unknown, sulfur ylides may be
formed in solution by deprotonating sulfonium ions
3with bases such as hydroxide ion (HO) or alkyl
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way 2) is not likely to be a problem since intramolecular
SN2 reactions rarely occur due to high energy transition
states (colinear geometry) [93]. The solution phase
methyl cation affinities (MCAs) of some biological
sulfur systems have been studied [94]. Unfortunately,
gas-phase MCAs are limited to experimental and theo-
retical estimates for dimethylsulfide [95] and theoretical
estimates of some other sulfides [96]. The bond
strengths of other breaking alkyl groups appear to be
unknown in both the condensed phase and the gas
phase. There have, however, been several studies on the
fragmentation reactions of sulfonium ions as studied by
mass spectrometry [97–100]. Scheme 3 (Pathway 3) is
highly unlikely given that the least stable carbocation is
formed (CH3
). Problems associated with Scheme 3
(Pathways 4 and 5) can be avoided by choosing an R
group that does not yield a stable ion (e.g., avoid benzyl
groups etc.) and does not form an alkene (e.g., avoid
Figure 1. Analysis of a methionine side chain
GAILMGAILK by quadrupole ion trap CID MS/
ion. (b) CID MS/MS product ion spectrum of
spectrum of the [M  2H]3 ion.ethyl or substituted ethyl groups and higher homo-logues), respectively. As the phenacylbromide derivati-
zation reagent allows these side reactions to be largely
avoided, this reagent has been employed for the re-
maining studies described herein.
Examination of the Fragmentation Behavior
of Fixed-Charge Phenacyl Sulfonium
Ion Derivatives of Methionine Containing Peptides
CID MS/MS and MS3 in a quadrupole ion trap mass
spectrometer. The gas-phase fragmentation behavior of
the fixed charge phenacyl sulfonium ion derivatives of
the methionine containing peptides, GAILMGAILX
(where X is either alanine, lysine, or arginine), VTMGH-
FCNFGK, VTMSHFWNFGK, and VTMGHFDNFGR
have been examined by CID MS/MS in a quadrupole
ion trap mass spectrometer. Illustrative of the general
observations made to date regarding this fragmentation
nacyl sulfonium ion fixed charge derivative of
a) CID MS/MS product ion spectrum of the M
M  H]2 ion. (c) CID MS/MS product ionphe
MS. (
the [behavior are the data shown in Figures 1– 6 and Figures
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spectra for the singly, doubly, and triply charged
phenacyl sulfonium ion derivatives of the model “tryp-
tic” peptide GAILMGAILK, each containing a single
fixed-charge corresponding to the sulfonium ion plus 0,
1, or 2 additional protons, respectively. In each case, the
overwhelmingly dominant fragmentation pathway cor-
responded to selective cleavage of the -CH-2-S bond at
the site of the fixed-charge on the methionine side
chain, resulting in the neutral loss of phenacyl methyl
sulfide (166 Da, CH3SCH2COC6H5) (labeled in Figure 1
as CH3SAP). This is in marked contrast to that ob-
served for CID MS/MS of the singly and doubly
protonated ions of the unmodified GAILMGAILK pep-
tide (Figure 2a and b, respectively), where the forma-
tion of a series of b- and y-type ions resulting from
dissociations occurring along the peptide backbone
were observed. The triply charged state of the fixed
charge sulfonium ion containing peptide (Figure 1c)
was the only partial exception, where some charged
side chain loss of protonated phenacyl methyl sulfide
was also observed. The MS/MS product ion spectra
obtained by CID MS/MS of the singly and doubly
charged forms of GAILMGAILA and the singly, dou-
bly, and triply charged forms of GALMGAILR, follow-
ing phenacyl sulfonium ion formation, are contained in
the supplemental material accompanying this manu-
script and are available from the authors upon request.
The fragmentation behavior of these ions was essen-
tially identical to that described above for the GAILM-
Figure 2. Analysis of GAILMGAILK by quadr
product ion spectrum of the [M  H] ion. (b) C
ion.GAILK peptide ions. Thus, in contrast to that typicallyobserved for the fragmentation of protonated peptide
ions [55], there does not appear to be any significant
charge state or basic amino acid composition depen-
dence to the fragmentation behavior of the side chain
fixed charge sulfonium ion containing peptides.
The specificity of sulfonium ion formation at me-
thionine residues under low pH conditions, even in
the presence of an S-alkyl cysteine amino acid, is
shown in Figure 3a. This figure shows the mass
spectrum obtained from ESI of the synthetic peptide
VTMGHFCNFGK following alkylation of the cysteine
residue with iodoacetamide under basic pH condi-
tions, then overnight reaction with phenacylbromide
under acidic conditions to yield the sulfonium ion.
Complete conversion of the peptide to the sulfonium
ion derivative was observed, with no evidence for
side reactions or additional alkylation products. CID
MS/MS of the doubly and triply charged precursor
ions (Figure 3b and c, respectively) resulted in the
exclusive loss of phenacyl methyl sulfide, indicative
of selective sulfonium ion formation at the thiom-
ethyl side chain of the methionine residue. Thus,
S-carboxyamidomethyl cysteine residues are not re-
active to sulfonium ion formation. Once again, the
selective fragmentation behavior is in stark contrast
to that observed from dissociation of the unmodified
peptide ions (Figure 4), where fragmentation occur-
ring along the peptide backbone to yield b- and
y-type ions was observed as the major dissociation
pathway. The MS/MS product ion spectra obtained
e ion trap mass spectrometry. (a) CID MS/MS
S/MS product ion spectrum of the [M  2H]2upol
ID Mby CID MS/MS of the doubly and triply charged
]3 io
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formation by reaction with phenacylbromide, are
contained in the supplemental material accompany-
ing this manuscript and are available from the au-
thors upon request. The fragmentation behavior of
these ions were essentially identical to those de-
scribed above for the VTMGHFCNFGK peptide, in-
dicating that the potentially competing reaction in-
volving enhanced “charge remote” fragmentation at
the C-terminal side of the aspartic acid residue does
not compete with the “charge directed” loss of the
fixed charge on the methionine side chain.
Potential mechanisms for the neutral loss of
CH3SCH2COC6H5 from the fixed-charge phenacyl sul-
fonium ion peptide derivatives are shown in Scheme 4.
Pathway 1 of Scheme 4 involves direct proton transfer
by an intramolecular nucleophile (Nu), such as the basic
side chains of arginine or lysine, the N-terminal amino
group, or a backbone amide carbonyl group, resulting
in elimination of the neutral to yield a 3-amino-1-
Figure 3. Analysis of a methionine side chain
VTMGHFC(S-carboxyamidomethyl)NFGK by q
spectrum obtained by ESI. (b) CID MS/MS pro
MS/MS product ion spectrum of the [M  2Hbutenoic acid (vinyl glycine) amino acid derivative,with a residue mass of 83 Da. Alternatively, the frag-
mentation may be directed by a nucleophilic attack
mechanism (Pathway 2 of Scheme 4), whereby an
adjacent amide carbonyl attacks the side chain to facil-
itate the neutral loss. Pathway 2 of Scheme 4 shows this
process occurring via nucleophilic attack by the amide
carbonyl on the N-terminal side of the methionine
sulfonium ion derivative, resulting in a 6-membered
cyclic product. However, nucleophilic attack by the
amide carbonyl on the C-terminal side of the methio-
nine sulfonium ion derivative, resulting in a 5-mem-
bered cyclic product may also be considered. A recent
MS/MS and molecular orbital study examining path-
ways for the loss of methanesulfenic acid from methi-
onine sulfoxide containing peptides has indicated that
both of these processes have similar transition state
barriers [56].
Intramolecular transfer of an acidic proton present in
either the precursor ion (Pathway 1), or in the product
ion formed following methionine side chain cleavage
nacyl sulfonium ion fixed charge derivative of
upole ion trap MS and CID MS/MS. (a) Mass
ion spectrum of the [M  H]2 ion. (c) CID
n.phe
uadr
duct(Pathway 2a or 2b) would result in “mobilization” of
1140 REID ET AL. J Am Soc Mass Spectrom 2005, 16, 1131–1150this proton, thereby allowing it to be involved in
subsequent fragmentation reactions according to the
mobile proton model developed for rationalizing the
fragmentation of protonated peptide ions [51–56]. Note
that if the reaction proceeds via Pathway 2 of Scheme 4,
the amide bond incorporated into the cyclic product
would not be amenable to subsequent cleavage. How-
ever, ring opening of the cyclic product via intramolec-
ular transfer (Pathway 2a) would yield the acyclic vinyl
glycine amino acid derivative, thereby allowing subse-
quent fragmentation of the product ion to occur on both
N- and C-terminal sides of the newly formed amino
acid residue.
Given that the sulfonium ion derivatized peptide
ions were observed to fragment almost exclusively
via the neutral loss of CH3SCH2COC6H5 to form a
charged product ion, a further stage of tandem mass
spectrometry (MS3) was employed, to generate addi-
tional structural information to allow identification of
the peptide by sequence analysis, and to obtain
evidence for the fragmentation mechanism. The spec-
tra obtained following CID MS3 of each of the neutral
loss product ions shown in Figures 1 and 3 above are
shown in Figures 5 and 6. MS3 of these ions, and
indeed all the [M  nH  CH3SAP]
(n1) product
ions formed by neutral loss from the sulfonium ion
fixed-charge peptide ions studied to date, resulted in
the formation of b- and y-type products ensuing from
dissociations along the peptide backbone, similar to
those observed by MS/MS of the unmodified peptide
[M  nH]n  precursor ions (Figures 2 and 4). In most
Figure 4. Analysis of VTMGHFC(S-carboxya
spectrometry. (a) CID MS/MS product ion spect
ion spectrum of the [M  3H]3 ion.cases, cleavage of the amide bonds on either side ofthe proposed vinyl glycine residue formed by loss of
the sulfonium ion side chain was observed follow-
ing MS3, suggesting that the fragmenting species
does contain an acyclic vinyl glycine residue, formed
either by Pathway 1 of Scheme 4 or by ring opening
of the cyclic product formed by Pathway 2a of
Scheme 4.
Energy Resolved CID MS/MS in a Quadrupole-
Time-of-Flight Mass Spectrometer
The dissociation reactions of the methionine side chain
fixed charge sulfonium ion peptide derivatives de-
scribed above have been further examined by energy
resolved CID in a quadrupole-time-of-flight (Q-TOF)
mass spectrometer. The energy resolved CID break-
down and appearance curves for the doubly charged
sulfonium ion derivative of GAILMGAILK are shown
in Figure 7. The breakdown curve of the precursor [M
 H]2 ion, the appearance/breakdown curve of the
initial neutral loss product ion (CH3SAP), as well as
the appearance curves of the individual product ions
and that of the summed product ion abundances (sum
of product ions) are indicated in Figure 7a. It can be
seen that there is essentially no overlap between the
breakdown of the [M  H]2 ion and the appearance
of the individual product ions, indicating that these ions
are not formed directly from the initial precursor.
Rather, these ions are formed from the initial neutral
loss product ion (CH3SAP). Given that there was
methyl)NFGK by quadrupole ion trap mass
of the [M  2H]2 ion. (b) CID MS/MS productmido
rumessentially no overlap in the collision energies required
3AP]3
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precursor ion abundance and the formation of second
generation product ions from the initial side chain
neutral loss product ion, automated data-dependent
acquisition methods could be readily developed,
whereby “low” energy quadrupole CID conditions are
employed for the identification of derivatized peptide
ions by the selective formation and detection of an
neutral loss product ion, followed by “high” energy
“pseudo MS3” CID conditions to obtain further struc-
tural information regarding the peptide sequence.
Representative product ion spectra taken under col-
lision energies sufficient to obtain 70–90% reduction of
the precursor ion (12 eV) and 70–90% reduction of the
initial neutral loss product ion (22 eV) abundances are
shown in Figure 7b and c, respectively. The product ion
spectra observed under these “low” and “high” energy
quadrupole CID conditions, respectively, are essentially
Figure 5. Multistage tandem mass spectrome
obtained from the methionine side chain phen
Figure 1. (a) CID MS3 product ion spectrum of th
CID MS3 product ion spectrum of the [M H
product ion spectrum of the [M  2H  CH3Sidentical to those observed by quadrupole ion trap massspectrometry MS/MS and MS3 experiments, indicating
that the time frame (millisecond versus microsecond
time scales for the ion trap and quadrupole experi-
ments, respectively) and mode of ion activation had no
appreciable effect on the fragmentation behavior. In-
deed, all of the peptides examined under these “low”
and “high” energy quadrupole CID conditions exhib-
ited very similar product ion spectra compared to the
equivalent ion trap derived MS/MS and MS3 spectra.
Identification of Methionine Containing Peptides
in a Triple Quadrupole Mass Spectrometer by
Neutral Loss Scan Code CID MS/MS of Their
Sulfonium Ion Fixed-Charge Derivatives
In order to demonstrate the selectivity of the fixed
charge derivatization and tandem mass spectrometry
S3) analysis of the neutral loss product ions
sulfonium ion derivative of GAILMGAILK in
  CH3SAP]
 product ion from Figure 1a. (b)
SAP]2 product ion from Figure 1b. (c) CID MS3
 product ion from Figure 1c.try (M
acyl
e [M
CHapproach for the identification of sulfonium ion con-
3CH3SAP]
3 product ion from Figure 3c.
1142 REID ET AL. J Am Soc Mass Spectrom 2005, 16, 1131–1150Figure 6. Multistage tandem mass spectrometry (MS3) analysis of the neutral loss product ions
obtained from the methionine side chain phenacyl sulfonium ion derivative of VTMGHFC(S-
carboxyamidomethyl)NFGK in Figure 3. (a) CID MS3 product ion spectrum of the [M  H 
CH SAP]2 product ion from Figure 3b. (b) CID MS3 product ion spectrum of the [M  2H Scheme 4
lision
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serum albumin was reduced and S-carboxyamido-
methylated under basic pH conditions, then subjected
to proteolytic digestion using trypsin. The resultant
peptide mixture then reacted under acidic conditions
with phenacylbromide to yield the side chain sulfonium
ion derivatives of methionine containing peptides
within the mixture. Ten pmol of this reduced, S-car-
boxyamidomethylated and sulfonium ion derivatized
tryptic peptide mixture was then subjected to on-line
capillary RP-HPLC ESI MS using a triple quadrupole
mass spectrometer. The total ion current trace obtained
from this analysis is shown in Figure 8a. Several hun-
dred multiply charged ions, corresponding to approxi-
mately 100 peptides, were observed by analysis of the
individual spectra acquired throughout the chromato-
graphic separation. In the absence of any a priori
knowledge regarding the protein sequence however,
identification of the sulfonium ion derivatized peptide
ions from these mass spectra would not be readily
Figure 7. CID MS/MS of the doubly charge
fixed-charge derivative of GAILMGAILK in a
Energy resolved breakdown curve for the [M 
[MH]2 ion obtained at a collision energy (la
spectra of the [M  H]2 ion obtained at a colachieved.Analysis of the same peptide mixture was carried
out by on-line capillary RP-HPLC and using a neutral
loss scan mode CID MS/MS experiment, to reveal those
peptides giving rise to the loss of 83 Th, i.e., the loss of
CH3SCH2COC6H5, 166 Da from doubly charged methi-
onine side chain sulfonium ion containing precursor
ions. The total ion current obtained from this experi-
ment is shown in Figure 9a. Four peaks were observed.
The mass spectra of the most abundant and least
abundant of these four peaks are shown in Figure 9b
and c. The masses of the major ions present in these four
peaks were found to closely correspond to those calcu-
lated for tryptic peptides containing each of the four
methionine residues within the bovine serum albumin
amino acid sequence. The mass spectra shown in Figure
8b and c, corresponding to the two regions of the total
ion current chromatogram shown by arrows in the MS
experiment, indicate that the ions detected in the neu-
tral loss scan mode experiment in Figure 9b and c are
present at relatively low abundance (the ion atm/z 799.4
ethionine side chain phenacyl sulfonium ion
drupole time-of-flight mass spectrometer. (a)
ion. (b) CID MS/MS product ion spectra of the
ory frame) of 12 V. (c) CID MS/MS product ion
energy (laboratory frame) of 22 V.d m
qua
H]2
boratin Figure 9b is only the eighth most abundant ion in
am in
1144 REID ET AL. J Am Soc Mass Spectrom 2005, 16, 1131–1150Figure 8b, and the ion at m/z 759.8 in Figure 9c is only
the third most abundant ion in Figure 9c).
Differential Quantitative Analysis by Neutral Loss
Scan Mode CID MS/MS of Stable Isotope Labeled
Fixed-Charge Containing Peptide Derivatives
in a Triple Quadrupole Mass Spectrometer
The potential for extending the sulfonium ion derivati-
zation approach toward the quantitation of differential
protein expression between two peptide samples of
interest has been examined by differential stable isotope
labeling and neutral loss scan mode MS/MS in a triple
quadrupole mass spectrometer. The synthetic peptide
GAIMGAILR was derivatized with either a “light”
phenacylbromide reagent containing only naturally
abundant isotopes (1H5-phenacylbromide) or a “heavy”
phenacylbromide reagent containing five deuterium
isotopes (2=,3=,4=,5=,6=-2H5-phenacylbromide). A nomi-
nal 1.0 pmol/L : 1.0 pmol/L mixture of the two
derivatized samples was then subjected to MS and
neutral loss scan mode MS/MS analysis. By measure-
ment of the peak intensities from the intact precursor
ions observed in the mass spectrum shown in Figure
Figure 8. (a) Total ion current trace from a 20
analysis of 10 pmol of a reduced and S-carbo
albumin, following sulfonium ion derivatization
two regions of the total ion current chromatogr10a, a ratio of 1.04:1 can be determined for the doubly(m/z 567.2 and 569.7) charged states of the peptides, and
a ratio of 1.06:1 for the triply (m/z 378.4 and 380.1)
charged states of the peptides. A ten times expanded
region of the mass spectrum between m/z 700–800
shows the level of chemical noise associated with this
data acquisition. In comparison, the neutral loss scan
mode MS/MS spectra of the same mixture (neutral
losses of 83 and 85.5 Th, respectively. for the doubly
charged precursor ions, and neutral losses of 55.3 and
57 Th, respectively, for the triply charged precursor
ions) are shown in Figure 10b. Again, the m/z 700–800
regions for each spectrum have been expanded ten
times to indicate the level of chemical noise. While the
observed ratios for the MS/MS neutral loss scan mode
ion abundances in Figure 10b are essentially identical to
those observed for the MS ion abundances in Figure
10a, the level of chemical noise is reduced by at least
two orders of magnitude compared with that observed
in the mass spectrum. Indeed, with the exception of
electronic noise, characterized by single data point
noise “spikes”, the neutral loss MS/MS spectra showed
a complete absence of nonspecific chemical noise along
the baseline. This is further demonstrated by the neutral
loss scan mode MS/MS data acquired from a nominal 1
i.d. capillary RP-HPLC-triple quadrupole MS
idomethylated tryptic digest of bovine serum
phenacylbromide. (b) and (c) Mass spectra of
dicated by arrows in Figure 8a.0 m
xyam
withpmol/L:0.1 pmol/L mixture of the light and heavy
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the ions obtained by this neutral loss scan mode
MS/MS experiment were determined to be 9.45:1 and
10.83:1 for the doubly and triply charged forms of the
peptides, respectively, and were similar to that ob-
served by MS, where ratios of 9.72:1 and 10.12:1, respec-
tively, were obtained (data not shown). Once again, the
level of chemical noise in the neutral loss scan mode
experiment was found to be at least two orders of
magnitude lower compared with that observed in the
mass spectrum. For a range of neutral loss scan mode
MS/MS experiments performed to date, with nominal
ratios of 0.1:1, 0.2:1.0, 0.5:1.0, 1.0:1.0, 1.0:0.5, 1.0:0.2, and
1.0:0.1, experimental errors were all within 10% of the
expected values.
A particular advantage of the MS/MS method for
differential quantitative analysis described here, over
those involving analysis by MS peak abundances alone,
is that both ions (i.e., light and heavy labeled forms) are
not required to be present in order for detection of one
of the pairs, and its origin (i.e., from the “light” or
“heavy” sample), to be obtained. Thus, quantitation of
peptide ions that are significantly over- or under-
expressed compared with a control may still be
Figure 9. (a) Total ion current trace from a 200
loss scan mode CID MS/MS analysis of 10 pmol
digest of bovine serum albumin, following sulf
and (c) Neutral loss scan mode mass spectra of
indicated by arrows in Figure 9a.achieved. Also, given that a common product is formedby neutral loss from both “light” and “heavy” labeled
ions, either product may be selected for further struc-
tural analysis by “high” energy pseudo CID or MS3.
One pmol each of the light and heavy derivatized
GAILMGAILR peptides were then combined and sub-
jected to capillary RP-HPLC MS analysis. The resultant
total ion current trace for this experiment is shown in
Figure 12a. By measurement of the peak intensities
from the mass spectrum shown in Figure 12b, obtained
by summing the individual spectra acquired across the
region of the chromatogram spanning 40.7 to 43.0 min,
abundance ratios of 1.06:1 and 1.04:1 were obtained
from the doubly and triply charged states of the pep-
tide, respectively. Neutral loss scan mode CID MS/MS
analysis of the same mixture, whereby neutral loss
scans of 83 and 85.5 Th (for the doubly charged precur-
sors) and 55.3 and 57 Th (for the triply charged precur-
sors), were obtained in successive scans throughout the
chromatographic separation (Figure 12c) and then
summed for display (Figure 12d), yielded an average
abundance ratio essentially identical to that obtained by
MS. Once again, the level of chemical noise in the
neutral loss scan mode MS/MS spectrum was signifi-
cantly reduced compared with that in the MS derived
d. capillary RP-HPLC-triple quadrupole neutral
reduced and S-carboxyamidomethylated tryptic
ion derivatization with phenacylbromide. (b)
regions of the total ion current chromatogramm i.
of a
onium
twodata, indicating that the MS/MS approach may provide
d ion
1146 REID ET AL. J Am Soc Mass Spectrom 2005, 16, 1131–1150significantly greater sensitivity than MS methods for
differential quantitative analysis. The approach could
also by readily applied to the “absolute” quantitative
analysis of protein expression, in an analogous manner
to recent reports whereby a known quantity of an
isotopically encoded peptide of interest is “spiked” into
a sample of interest as an internal standard [101].
Less than 10% separation of the 1H5- and
2H5 forms
of the fixed charge sulfonium ion derivatives across the
chromatographic peaks in Figure 12 was observed,
indicating that there is not a strong deuterium isotope
effect on the chromatographic fractionation of these
fixed charge derivatives. This is consistent with recent
reports describing the factors controlling deuterium
isotope effects on chromatography [35, 36]. In future
Figure 10. (a) Triple quadrupole mass spec
2H5-containing methionine side chain phenacyl
GAILR. (b) Neutral loss scan mode CID MS/MS
charged ions and 5.3 and 57.0 Th for triply charge
Figure 11. Triple quadrupole neutral loss scan
85.5 Th for doubly charged ions and 5.3 and 57.
mixture of 1H - and 2H -containing methionin5 5
derivative of GAILMGAILR.work, however, replacement of 2H with 13C within the
“heavy” derivatization reagent will ensure that light
and heavy isotopic variants coelute upon HPLC frac-
tionation, thereby allowing more accurate quantitation
without the need for signal averaging across an entire
chromatographic peak. For future applications involv-
ing the analysis of methionine sulfonium ion containing
peptides from complex biologically derived mixtures,
the fixed charge derivatives could be pre-enriched by a
range of methods prior to mass spectrometry analysis,
including diagonal chromatography [102], strong cation
exchange [76, 103], or solid phase capture [77], thereby
simplifying the mixture complexity and minimizing the
potential for m/z overlap between unlabeled and la-
beled peptide ions. However, either of the two later
of a 1.0:1.0 pmol/L mixture of 1H5- and
onium ion fixed charge derivative of GAILM-
tra (neutral losses of 83.0 and 85.5 Th for doubly
s) from the 1H5- and
2H5-containing derivatives.
CID MS/MS spectra (neutral losses of 83.0 and
for triply charged ions) from a 1.0:0.1 pmol/L
e chain phenacyl sulfonium ion fixed chargetrum
sulf
specmode
0 Th
e sid
in r
1147J Am Soc Mass Spectrom 2005, 16, 1131–1150 ANALYSIS OF METHIONINE CONTAINING PEPTIDESapproaches is preferred because of the ability to obtain
direct enrichment of labeled peptides without require-
ment for separate chromatographic analysis of both
unmodified and modified samples.
Conclusions
This study describes a novel strategy for the selective
identification of methionine containing peptides and
proteins via the formation of side chain “fixed-charge”
sulfonium ion derivatives. These sulfonium ions un-
dergo exclusive loss of the derivatized methionine side
chain upon CID MS/MS, with concomitant formation
of a single characteristic product ion, independent of
charge state or amino acid composition. Further struc-
tural interrogation of identified peptide ions is achieved
by subjecting the characteristic MS/MS product ion to
multistage MS/MS (MS3) in a quadrupole ion trap mass
spectrometer, or by energy resolved “pseudo” MS3 in a
triple quadrupole mass spectrometer. While the side
chain fixed charge derivatization approach has been
demonstrated here for a specific amino acid (methio-
nine) and derivatization reaction (sulfonium ions), in
principle this approach should be readily applicable to
other types of amino acid residues and derivatization
Figure 12. 75 m i.d. capillary RP-HPLC-MS an
methionine side chain phenacyl sulfonium ion fix
current trace obtained by MS analysis. (b) Sum
indicated in Panel (a). (c) Total ion current trace
(neutral losses of 83.0 and 85.5 Th for doubly cha
(d) Summed mass spectrum of the 40.7 to 43.0 mreactions.Acknowledgments
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